NOTE: Temporary price increase due to shortage from USA supplier is resulting in our sourcing it at a higher cost from Canada.
AGRYLIN (ANAGRELIDE HCL)
Agrylin is a platelet-reducing agent prescribed for treating myeloproliferative disorders such as polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF). Myeloproliferative disorders, shortened to MPD, is a collective name for conditions that cause blood cells, namely platelets, white blood cells and red blood cells, to grow irregularly in your bone marrow. Taking Agrylin or generic Anagrelide HCl will slow the production of platelets in your body which are cells that help your blood clot. Without medication, it can be difficult for your blood to flow as it should. The generic alternative is not manufactured by the company that makes the brand product.
Conditions Treated by Agrylin
Polycythemia vera occurs when your bone marrow makes an overabundance of blood cells, red blood cells specifically. The vast majority of those with PV carry a blood mutation. Essential thrombocytosis occurs when your body over-produces platelet cells; these are required for clotting. With the increased ability to clot, there is a risk of blood vessel blockage that could lead to heart attack or stroke. Myelofibrosis, primary or idiopathic, happens when your bone marrow produces too much collagen or fibrous tissue that can impede the marrow’s capacity for producing blood cells. It is believed that genetics and environmental factors can result in MPDs.
Warnings for Agrylin
Tell your physician if you have any allergies or a history of heart problems, lung, liver, or kidney problems. List all current OTC and Rx medications you are on and include any vitamin and dietary supplements. Combining some drugs can produce unwanted side effects or change how Agrylin works in your body.
Possible Side Effects of Agrylin
· Body aches or pains
· Bloating of face or extremities
· Sore throat or fever
Drugs Similar to Agrylin